Last reviewed · How we verify
Angiomyolipoma of kidney
Approved treatments
- Afinitor · Novartis
Afinitor works by blocking the mTOR protein, which is involved in cell growth and division. - Afinitor · Central European Society for Anticancer Drug Research
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Angiomyolipoma of kidney patent landscape — cliff calendar, originator estates, attackable patents
- Angiomyolipoma of kidney treatment landscape brief
- Angiomyolipoma of kidney treatment updates RSS
Frequently asked questions about Angiomyolipoma of kidney
What drugs treat Angiomyolipoma of kidney?
Tracked treatments include Afinitor.
What is the treatment for Angiomyolipoma of kidney?
Standard treatment for Angiomyolipoma of kidney includes Afinitor. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Angiomyolipoma of kidney patent cliff · Angiomyolipoma of kidney CI report
- Treatment: Afinitor · Novartis
- Treatment: Afinitor · Central European Society for Anticancer Drug Research
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing